157 related articles for article (PubMed ID: 15683541)
1. Elevated glutamine/glutamate ratio in cerebrospinal fluid of first episode and drug naive schizophrenic patients.
Hashimoto K; Engberg G; Shimizu E; Nordin C; Lindström LH; Iyo M
BMC Psychiatry; 2005 Jan; 5():6. PubMed ID: 15683541
[TBL] [Abstract][Full Text] [Related]
2. Reduced D-serine to total serine ratio in the cerebrospinal fluid of drug naive schizophrenic patients.
Hashimoto K; Engberg G; Shimizu E; Nordin C; Lindström LH; Iyo M
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jun; 29(5):767-9. PubMed ID: 15939521
[TBL] [Abstract][Full Text] [Related]
3. Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study.
Ohrmann P; Siegmund A; Suslow T; Pedersen A; Spitzberg K; Kersting A; Rothermundt M; Arolt V; Heindel W; Pfleiderer B
J Psychiatr Res; 2007 Oct; 41(8):625-34. PubMed ID: 16949099
[TBL] [Abstract][Full Text] [Related]
4. Glutamatergic changes in the cerebral white matter associated with schizophrenic exacerbation.
Ota M; Ishikawa M; Sato N; Hori H; Sasayama D; Hattori K; Teraishi T; Nakata Y; Kunugi H
Acta Psychiatr Scand; 2012 Jul; 126(1):72-8. PubMed ID: 22432602
[TBL] [Abstract][Full Text] [Related]
5. Glutamatergic neurometabolites in clozapine-responsive and -resistant schizophrenia.
Goldstein ME; Anderson VM; Pillai A; Kydd RR; Russell BR
Int J Neuropsychopharmacol; 2015 Jan; 18(6):. PubMed ID: 25603859
[TBL] [Abstract][Full Text] [Related]
6. A CSF and postmortem brain study of D-serine metabolic parameters in schizophrenia.
Bendikov I; Nadri C; Amar S; Panizzutti R; De Miranda J; Wolosker H; Agam G
Schizophr Res; 2007 Feb; 90(1-3):41-51. PubMed ID: 17156977
[TBL] [Abstract][Full Text] [Related]
7. CSF of neuroleptic-naive first-episode schizophrenic patients: levels of biogenic amines, substance P, and peptides derived from chromogranin A (GE-25) and secretogranin II (secretoneurin).
Miller C; Kirchmair R; Troger J; Saria A; Fleischhacker WW; Fischer-Colbrie R; Benzer A; Winkler H
Biol Psychiatry; 1996 Jun; 39(11):911-8. PubMed ID: 9162202
[TBL] [Abstract][Full Text] [Related]
8. Abnormality in glutamine-glutamate cycle in the cerebrospinal fluid of cognitively intact elderly individuals with major depressive disorder: a 3-year follow-up study.
Hashimoto K; Bruno D; Nierenberg J; Marmar CR; Zetterberg H; Blennow K; Pomara N
Transl Psychiatry; 2016 Mar; 6(3):e744. PubMed ID: 26926880
[TBL] [Abstract][Full Text] [Related]
9. Increased serum levels of glutamate in adult patients with autism.
Shinohe A; Hashimoto K; Nakamura K; Tsujii M; Iwata Y; Tsuchiya KJ; Sekine Y; Suda S; Suzuki K; Sugihara G; Matsuzaki H; Minabe Y; Sugiyama T; Kawai M; Iyo M; Takei N; Mori N
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Dec; 30(8):1472-7. PubMed ID: 16863675
[TBL] [Abstract][Full Text] [Related]
10. Analysis of glutamine, glutamate, pyroglutamate, and GABA in cerebrospinal fluid using ion pairing HPLC with positive electrospray LC/MS/MS.
Eckstein JA; Ammerman GM; Reveles JM; Ackermann BL
J Neurosci Methods; 2008 Jun; 171(2):190-6. PubMed ID: 18433876
[TBL] [Abstract][Full Text] [Related]
11. Markers of glutamate signaling in cerebrospinal fluid and serum from patients with bipolar disorder and healthy controls.
Pålsson E; Jakobsson J; Södersten K; Fujita Y; Sellgren C; Ekman CJ; Ågren H; Hashimoto K; Landén M
Eur Neuropsychopharmacol; 2015 Jan; 25(1):133-40. PubMed ID: 25482684
[TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal fluid glutamate levels in chronic migraine.
Peres MF; Zukerman E; Senne Soares CA; Alonso EO; Santos BF; Faulhaber MH
Cephalalgia; 2004 Sep; 24(9):735-9. PubMed ID: 15315529
[TBL] [Abstract][Full Text] [Related]
13. Increased prefrontal and hippocampal glutamate concentration in schizophrenia: evidence from a magnetic resonance spectroscopy study.
van Elst LT; Valerius G; Büchert M; Thiel T; Rüsch N; Bubl E; Hennig J; Ebert D; Olbrich HM
Biol Psychiatry; 2005 Nov; 58(9):724-30. PubMed ID: 16018980
[TBL] [Abstract][Full Text] [Related]
14. Metabolic alterations in medication-free patients with bipolar disorder: a 3T CSF-corrected magnetic resonance spectroscopic imaging study.
Port JD; Unal SS; Mrazek DA; Marcus SM
Psychiatry Res; 2008 Feb; 162(2):113-21. PubMed ID: 18164911
[TBL] [Abstract][Full Text] [Related]
15. Excitatory amino acids and multiple sclerosis: evidence from cerebrospinal fluid.
Sarchielli P; Greco L; Floridi A; Floridi A; Gallai V
Arch Neurol; 2003 Aug; 60(8):1082-8. PubMed ID: 12925363
[TBL] [Abstract][Full Text] [Related]
16. A novel technique to study the brain's response to pain: proton magnetic resonance spectroscopy.
Mullins PG; Rowland LM; Jung RE; Sibbitt WL
Neuroimage; 2005 Jun; 26(2):642-6. PubMed ID: 15907322
[TBL] [Abstract][Full Text] [Related]
17. The relation between peripheral and central glutamate and glutamine in healthy male volunteers.
Shulman Y; Grant S; Seres P; Hanstock C; Baker G; Tibbo P
J Psychiatry Neurosci; 2006 Nov; 31(6):406-10. PubMed ID: 17136218
[TBL] [Abstract][Full Text] [Related]
18. Decreased serum levels of D-serine in patients with schizophrenia: evidence in support of the N-methyl-D-aspartate receptor hypofunction hypothesis of schizophrenia.
Hashimoto K; Fukushima T; Shimizu E; Komatsu N; Watanabe H; Shinoda N; Nakazato M; Kumakiri C; Okada S; Hasegawa H; Imai K; Iyo M
Arch Gen Psychiatry; 2003 Jun; 60(6):572-6. PubMed ID: 12796220
[TBL] [Abstract][Full Text] [Related]
19. Amino acids and transaminases activity in ventricular CSF and in brain of normal and Alzheimer patients.
D'Aniello A; Fisher G; Migliaccio N; Cammisa G; D'Aniello E; Spinelli P
Neurosci Lett; 2005 Nov; 388(1):49-53. PubMed ID: 16039064
[TBL] [Abstract][Full Text] [Related]
20. Cerebrospinal fluid levels of glutamate and corticotropin releasing hormone in major depression before and after treatment.
Garakani A; Martinez JM; Yehuda R; Gorman JM
J Affect Disord; 2013 Apr; 146(2):262-5. PubMed ID: 22840611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
